New NICE advice could put millions more U.K. patients on statins

The U.K.'s cost-effectiveness agency is recommending much broader use of statin drugs now that they are available as cheaper generics. A similar call in the U.S. touched off a debate over preventive use of the meds. The recommendation would put millions more patients on cholesterol-lowering pills, and could boost the size of the market for branded drugs, such as AstraZeneca's ($AZN) Crestor. Report

Suggested Articles

A self-proclaimed former employee at Novartis’ Beijing office accused the Swiss drugmaker of expensing fake academic events to offer kickbacks to doctors.

Novo Nordisk just won an FDA approval that could help it stand out in the crowded—and competitive—basal insulin category.

Pfizer is training pharmacists in the U.K. to handle over-the-counter Viagra.